APA (7th ed.) Citation

Bakker, G., Caan, M., Vingerhoets, W., Da Silva-Alves, F., De Koning, M., Bloemen, O., . . . Amelsvoort, T. (2015). P.3.b.026 Differences in cortical morphology between 22q11.2 deletion syndrome patients and patients at ultra-high risk for psychotic disorders. European Neuropsychopharmacology, 25, S478. https://doi.org/10.1016/S0924-977X(15)30650-7

Chicago Style (17th ed.) Citation

Bakker, G., et al. "P.3.b.026 Differences in Cortical Morphology Between 22q11.2 Deletion Syndrome Patients and Patients at Ultra-high Risk for Psychotic Disorders." European Neuropsychopharmacology 25 (2015): S478. https://doi.org/10.1016/S0924-977X(15)30650-7.

MLA (9th ed.) Citation

Bakker, G., et al. "P.3.b.026 Differences in Cortical Morphology Between 22q11.2 Deletion Syndrome Patients and Patients at Ultra-high Risk for Psychotic Disorders." European Neuropsychopharmacology, vol. 25, 2015, p. S478, https://doi.org/10.1016/S0924-977X(15)30650-7.